FDA: similarities between J&J and AstraZeneca vaccines are 'plainly obvious'

There appear to be similarities between the rare blood clotting events possibly associated with Johnson & Johnson’s coronavirus vaccine and the AstraZeneca coronavirus vaccine, Dr. Peter Marks, director of the US Food and Drug Administration's Center for Biologics Evaluation and Research, said during a virtual briefing on Tuesday. Pročitaj više